Literature DB >> 19811284

Oxidation of the alarmin high-mobility group box 1 protein (HMGB1) during apoptosis.

Vilma Urbonaviciute1, Silke Meister, Barbara G Fürnrohr, Benjamin Frey, Eva Gückel, Georg Schett, Martin Herrmann, Reinhard E Voll.   

Abstract

The architectural chromosomal protein high-mobility group box 1 protein (HMGB1) acts as an alarmin when released from cells. It is involved in the pathogenesis of inflammatory and autoimmune diseases. HMGB1 can undergo post-translational modifications including oxidation. However, the mechanisms and functional relevance of HMGB1 oxidation are not yet understood. Increased concentrations of reactive oxygen species (ROS) have been reported during apoptosis and necrosis. Hence, we investigated the oxidative status of HMGB1 in dead cells. Immunoblot analyses under reducing and non-reducing conditions revealed that HMGB1 is oxidized in dead cells. Moreover, tagging of oxidized cysteine residues by a maleimide moiety linked to polyethylene glycol showed that HMGB1 passively released from primary and secondary necrotic cells was predominantly oxidized. Also HMGB1 in plasma of patients with systemic lupus was reversibly oxidized. In conclusion, HMGB1 undergoes reversible oxidative modifications at cysteine residues during cell death, which may modulate its biological properties.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19811284     DOI: 10.1080/08916930902831803

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  25 in total

1.  Autoantibodies to box A of high mobility group box 1 in systemic lupus erythematosus.

Authors:  F Schaper; K de Leeuw; G Horst; F Maas; H Bootsma; P Heeringa; P C Limburg; J Westra
Journal:  Clin Exp Immunol       Date:  2017-03-27       Impact factor: 4.330

Review 2.  The expression of HMGB1 on microparticles released during cell activation and cell death in vitro and in vivo.

Authors:  David S Pisetsky
Journal:  Mol Med       Date:  2014-04-01       Impact factor: 6.354

3.  Oxidative stress-dependent contribution of HMGB1 to the interplay between apoptosis and autophagy in diabetic rat liver.

Authors:  Anja Petrović; Desanka Bogojević; Aleksandra Korać; Igor Golić; Sofija Jovanović-Stojanov; Vesna Martinović; Svetlana Ivanović-Matić; Jelena Stevanović; Goran Poznanović; Ilijana Grigorov
Journal:  J Physiol Biochem       Date:  2017-07-10       Impact factor: 4.158

4.  Redox state-dependent interaction of HMGB1 and cisplatin-modified DNA.

Authors:  Semi Park; Stephen J Lippard
Journal:  Biochemistry       Date:  2011-02-28       Impact factor: 3.162

5.  Genomic analysis and differential expression of HMG and S100A family in human arthritis: upregulated expression of chemokines, IL-8 and nitric oxide by HMGB1.

Authors:  Ashok R Amin; Abul B M M K Islam
Journal:  DNA Cell Biol       Date:  2014-06-06       Impact factor: 3.311

Review 6.  High-mobility group box 1, oxidative stress, and disease.

Authors:  Daolin Tang; Rui Kang; Herbert J Zeh; Michael T Lotze
Journal:  Antioxid Redox Signal       Date:  2011-04-01       Impact factor: 8.401

Review 7.  Redox modulation of HMGB1-related signaling.

Authors:  Christina Janko; Milos Filipović; Luis E Munoz; Christine Schorn; Georg Schett; Ivana Ivanović-Burmazović; Martin Herrmann
Journal:  Antioxid Redox Signal       Date:  2013-03-19       Impact factor: 8.401

8.  Life after death: targeting high mobility group box 1 in emergent cancer therapies.

Authors:  Z Sheng Guo; Zuqiang Liu; David L Bartlett; Daolin Tang; Michael T Lotze
Journal:  Am J Cancer Res       Date:  2013-01-18       Impact factor: 6.166

Review 9.  The complex role of DNA, histones and HMGB1 in the pathogenesis of SLE.

Authors:  David S Pisetsky
Journal:  Autoimmunity       Date:  2014-06-11       Impact factor: 2.815

Review 10.  Recent developments in the role of high-mobility group box 1 in systemic lupus erythematosus.

Authors:  Fleur Schaper; Johanna Westra; Marc Bijl
Journal:  Mol Med       Date:  2014-03-13       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.